BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Sciele Pharma, Inc. 

Five Concourse Parkway
Suite 1800
Atlanta  Georgia  30328  U.S.A.
Phone: 800-461-3696 Fax:


SEARCH JOBS


Industry
Pharmaceutical






 Company News
Shionogi Pharma, Inc. to Halve US Sales Force as Generics Hit Former Sciele Pharma, Inc. (SCRX) Business 9/8/2010 11:50:49 AM    More...
Sciele Pharma, Inc. (SCRX), a Shionogi Group Company, Announces Name Change to Shionogi Pharma, Inc. 1/12/2010 11:14:55 AM    More...
Sciele Pharma, Inc. (SCRX) Introduces Adrenaclick(TM) (epinephrine injection, USP) Auto-Injector for the Emergency Treatment of Anaphylaxis 1/7/2010 10:10:09 AM    More...
Pivotal Study For Sciele Pharma, Inc. (SCRX)'s PSD502 -- The First Potential Treatment For Premature Ejaculation 11/19/2009 7:35:41 AM    More...
Sciele Pharma, Inc. (SCRX), a Shionogi & Co., Ltd. Company, to Acquire Addrenex Pharmaceuticals, a U.S. Specialty Pharmaceutical Company 11/16/2009 10:36:14 AM    More...
Sciele Pharma, Inc. (SCRX) Submits New Drug Application to FDA for Glycopyrrolate Oral Solution, a Treatment for Chronic, Moderate-to-Severe Drooling in Pediatric Patients 9/28/2009 10:08:18 AM    More...
Sciele Pharma, Inc. (SCRX) Announces Availability of ULESFIA(TM) 8/5/2009 9:12:33 AM    More...
Sciele Pharma, Inc. (SCRX) and Plethora Solutions Holdings Announce Positive Results of Final Phase III Pivotal Trial for PSD502 for Premature Ejaculation 7/29/2009 9:44:44 AM    More...
Sciele Pharma, Inc. (SCRX) Says Scraps $150 Million Plan to Buy Victory Pharma, Inc. 7/10/2009 6:41:56 AM    More...
Sciele Pharma, Inc. (SCRX) Announces Availability of Ulesfia (Benzyl Alcohol Lotion 5%), First Prescription Non-Neurotoxic Head Lice Treatment 7/9/2009 9:15:40 AM    More...
12345678910...

//-->